I was thrilled to hear that some of our elected members of Congress are finally working on proactive legislation that might benefit all of us. This is especially encouraging after watching with much discouragement the high level of discord and dysfunction that has become commonplace in the Capitol. Recently, some […]
Category: Articles
The U.S. Food and Drug Administration (FDA) wants to remind the public what a good job it’s been doing in monitoring drugs both before and after they are marketed. In a report issued over the weekend, April 21, “Advances in FDA’s Safety Program for Marketed Drugs,” the agency pats itself […]
We now have a better idea of how one synthetic mesh medical device maker, American Medical Systems, Inc., plans to defend itself against the 318 lawsuits that have been consolidated in the Southern District of West Virginia before The Honorable Joseph R. Goodwin. In a Position Statement, issued and filed […]
This is the typical refrain from so many of our clients who were implanted with defective metal-on-metal hip implants made by orthopedic giants like DePuy, Stryker, Wright Medical, and Zimmer. The irony is that those who utter those words are actually very close to the emerging stereotype for these clients. […]
The “antipsychotic” class of drugs is distributed liberally in nursing homes. Antipsychotics including Risperdal, Seroquel, Zyprexa, and Abilify, are frequently given to the elderly who are suffering from dementia so they are easier to control. It’s a handy tool in a nursing home that is understaffed and needs to find […]
A newly published study finds that first-time users of a class of drugs to treat osteoporosis may be at an increased risk of serious inflammatory eye disease. Bisphosphonates such as Fosamax and Actonel, which are taken orally, are two of the most commonly prescribed drugs in that class. Published in […]
We hear from them every day – consumers who trust and believe their doctor only to find out things like what Consumer Reports (CR) investigates in its May issue. Surprisingly, the majority of medical devices never have to pass through any sort of safety and efficacy standard with the Food […]
Better late than never? The U.S. Food and Drug Administration (FDA) will hold a gathering of scientific and clinical experts to discuss whether metal-on-metal (MoM) artificial hip systems should undergo more rigorous scientific scrutiny before they are implanted in U.S. patients, which sounds infinitely reasonable. On Thursday, March 29, the […]
The U.S. Food and Drug Administration (FDA) has revised its recommendations for the popular antidepressant, Celexa (citalopram hydrobromide). Last August, the FDA warned Celexa should be limited to doses no greater than 40 mg per day because of a risk of abnormal electrical activity in the heart known as Torsade […]
Johnson & Johnson (J&J) rarely responds to negative news, which it’s been experiencing a lot of lately, usually relying on the news cycles to wash away unfavorable reports. But in an unusual move, a J&J spokesman recently did defend the company from the latest blow – that the health care […]
